May 6, 2025 8:30 am EDT Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
Apr 21, 2025 11:19 am EDT Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
Mar 11, 2025 7:30 am EDT Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
Mar 7, 2025 8:30 am EST Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
Mar 6, 2025 8:30 am EST Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025
Feb 11, 2025 8:30 am EST Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference
Feb 10, 2025 8:30 am EST Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
Jan 10, 2025 8:30 am EST Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors
Jan 7, 2025 8:30 am EST Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission
Jan 6, 2025 8:30 am EST Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
